Ischaemic conditioning and targeting reperfusion injury: a 30 year voyage of discovery

To commemorate the auspicious occasion of the 30th anniversary of IPC, leading pioneers in the field of cardioprotection gathered in Barcelona in May 2016 to review and discuss the history of IPC, its evolution to IPost and RIC, myocardial reperfusion injury as a therapeutic target, and future targets and strategies for cardioprotection. This article provides an overview of the major topics discussed at this special meeting and underscores the huge importance and impact, the discovery of IPC has made in the field of cardiovascular research.

[1]  P. Libby,et al.  Precordial S-T segment elevation mapping: an atraumatic method for assessing alterations in the extent of myocardial ischemic injury. The effects of pharmacologic and hemodynamic interventions. , 1972, The American journal of cardiology.

[2]  R. Jennings,et al.  Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. , 1986, Circulation.

[3]  G. Buckberg.  Strategies and logic of cardioplegic delivery to prevent, avoid, and reverse ischemic and reperfusion damage. , 1987, The Journal of thoracic and cardiovascular surgery.

[4]  A. Cordell,et al.  Reperfusion injury after temporary coronary occlusion. , 1988, The Journal of thoracic and cardiovascular surgery.

[5]  R. Currie,et al.  Heat‐Shock Response Is Associated With Enhanced Postischemic Ventricular Recovery , 1988, Circulation research.

[6]  Juan A. Vasquez,et al.  Myocardial protection with preconditioning. , 1990, Circulation.

[7]  R. Jennings,et al.  Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode. , 1990, Circulation research.

[8]  A. M. Lefer,et al.  Time course of endothelial dysfunction and myocardial injury during myocardial ischemia and reperfusion in the cat. , 1990, Circulation.

[9]  B. Siegmund,et al.  Temporary contractile blockade prevents hypercontracture in anoxic-reoxygenated cardiomyocytes. , 1990, The American journal of physiology.

[10]  J. Downey,et al.  Protection Against Infarction Afforded by Preconditioning is Mediated by A1 Adenosine Receptors in Rabbit Heart , 1991, Circulation.

[11]  P. Brecher,et al.  Rapid expression of heat shock protein in the rabbit after brief cardiac ischemia. , 1991, The Journal of clinical investigation.

[12]  M. Hori,et al.  Staged Reperfusion Attenuates Myocardial Stunning in Dogs: Role of Transient Acidosis During Early Reperfusion , 1991, Circulation.

[13]  B. Siegmund,et al.  Temporary contractile blockade prevents hypercontracture in anoxic-reoxygenated cardiomyocytes. , 1991 .

[14]  B. Siegmund,et al.  Recovery of anoxic-reoxygenated cardiomyocytes from severe Ca2+ overload. , 1992, The American journal of physiology.

[15]  G. Grover,et al.  Blockade of ischaemic preconditioning in dogs by the novel ATP dependent potassium channel antagonist sodium 5-hydroxydecanoate. , 1992, Cardiovascular research.

[16]  F. Fernández‐Avilés,et al.  Selective Inhibition of the Contractile Apparatus: A New Approach to Modification of Infarct Size, Infarct Composition, and Infarct Geometry During Coronary Artery Occlusion and Reperfusion , 1992, Circulation.

[17]  R. Kloner,et al.  Regional Ischemic 'Preconditioning' Protects Remote Virgin Myocardium From Subsequent Sustained Coronary Occlusion , 1993, Circulation.

[18]  D. Latchman,et al.  Cardiac stress protein elevation 24 hours after brief ischemia or heat stress is associated with resistance to myocardial infarction. , 1993, Circulation.

[19]  M. Hori,et al.  Delayed effects of sublethal ischemia on the acquisition of tolerance to ischemia. , 1993, Circulation research.

[20]  R. Ferrari,et al.  Heat stress limits infarct size in the isolated perfused rabbit heart. , 1993, Cardiovascular research.

[21]  J. Downey,et al.  Evidence that translocation of protein kinase C is a key event during ischemic preconditioning of rabbit myocardium. , 1994, Journal of molecular and cellular cardiology.

[22]  D. Duncker,et al.  Myocardial protection by brief ischemia in noncardiac tissue. , 1996, Circulation.

[23]  E. Marbán,et al.  Synergistic modulation of ATP-sensitive K+ currents by protein kinase C and adenosine. Implications for ischemic preconditioning. , 1996, Circulation research.

[24]  D. Yellon,et al.  Angina reassessed: pain or protector? , 1996, The Lancet.

[25]  H. Sato,et al.  Gradual reperfusion reduces infarct size and endothelial injury but augments neutrophil accumulation. , 1997, The Annals of thoracic surgery.

[26]  M. Amrani,et al.  Relative susceptibility of endothelium and myocardial cells to ischaemia-reperfusion injury. , 1997, Acta physiologica Scandinavica.

[27]  W. Chen,et al.  Regulation of the Ca2+ gradient across the sarcoplasmic reticulum in perfused rabbit heart. A 19F nuclear magnetic resonance study. , 1998, Circulation research.

[28]  Z. Szilvássy,et al.  Adaptation to myocardial stress in disease states: is preconditioning a healthy heart phenomenon? , 1998, Trends in pharmacological sciences.

[29]  H M Piper,et al.  A fresh look at reperfusion injury. , 1998, Cardiovascular research.

[30]  M. Hori,et al.  Evidence for the delayed effect in human ischemic preconditioning: prospective multicenter study for preconditioning in acute myocardial infarction. , 1999, Journal of the American College of Cardiology.

[31]  J. Soler‐Soler,et al.  Propagation of cardiomyocyte hypercontracture by passage of Na(+) through gap junctions. , 1999, Circulation research.

[32]  B. Sancak,et al.  Does remote organ ischaemia trigger cardiac preconditioning during coronary artery surgery? , 2000, Pharmacological research.

[33]  J. Downey,et al.  Opening of Mitochondrial KATP Channels Triggers the Preconditioned State by Generating Free Radicals , 2000, Circulation research.

[34]  M. Bilińska,et al.  Delayed attenuation of myocardial ischemia with repeated exercise in subjects with stable angina: a possible model for the second window of protection? , 2000, Basic Research in Cardiology.

[35]  G. Heusch.  Nitroglycerin and delayed preconditioning in humans: yet another new mechanism for an old drug? , 2001, Circulation.

[36]  S. Smart,et al.  Changes in [Na(+)](i), compartmental [Ca(2+)], and NADH with dysfunction after global ischemia in intact hearts. , 2001, American journal of physiology. Heart and circulatory physiology.

[37]  J. Downey,et al.  Acetylcholine, Bradykinin, Opioids, and Phenylephrine, but not Adenosine, Trigger Preconditioning by Generating Free Radicals and Opening Mitochondrial KATP Channels , 2001, Circulation research.

[38]  Yigang Wang,et al.  Calcium preconditioning inhibits mitochondrial permeability transition and apoptosis. , 2001, American journal of physiology. Heart and circulatory physiology.

[39]  R. Strasser,et al.  Remote preconditioning by infrarenal occlusion of the aorta protects the heart from infarction: a newly identified non-neuronal but PKC-dependent pathway. , 2002, Cardiovascular research.

[40]  D. Latchman,et al.  Urocortin protects the heart from reperfusion injury via upregulation of p42/p44 MAPK signaling pathway. , 2002, American journal of physiology. Heart and circulatory physiology.

[41]  L. Opie,et al.  Identification of a novel role for sphingolipid signaling in TNF alpha and ischemic preconditioning mediated cardioprotection. , 2002, Journal of molecular and cellular cardiology.

[42]  P. Pizcueta,et al.  Platelets activated by transient coronary occlusion exacerbate ischemia-reperfusion injury in rat hearts. , 2002, American journal of physiology. Heart and circulatory physiology.

[43]  D. Yellon,et al.  Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning? , 2002, Cardiovascular research.

[44]  A. Rodríguez-Sinovas,et al.  Protection afforded by ischemic preconditioning is not mediated by effects on cell-to-cell electrical coupling during myocardial ischemia-reperfusion. , 2003, American journal of physiology. Heart and circulatory physiology.

[45]  H. Hayashi,et al.  Protective effects of hydrogen peroxide against ischemia/reperfusion injury in perfused rat hearts. , 2003, Circulation journal : official journal of the Japanese Circulation Society.

[46]  J. Downey,et al.  Preconditioning the myocardium: from cellular physiology to clinical cardiology. , 2003, Physiological reviews.

[47]  P. Ferdinandy.  Myocardial ischaemia/reperfusion injury and preconditioning: effects of hypercholesterolaemia/hyperlipidaemia , 2003, British journal of pharmacology.

[48]  R. Guyton,et al.  Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. , 2003, American journal of physiology. Heart and circulatory physiology.

[49]  Pier D Lambiase,et al.  Exercise-induced ischemia initiates the second window of protection in humans independent of collateral recruitment. , 2003, Journal of the American College of Cardiology.

[50]  L. Becker.  Myocardial Reperfusion Injury , 2004, Journal of Thrombosis and Thrombolysis.

[51]  R. Guyton,et al.  Postconditioning attenuates myocardial ischemia-reperfusion injury by inhibiting events in the early minutes of reperfusion. , 2004, Cardiovascular research.

[52]  D. Yellon,et al.  New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway. , 2004, Cardiovascular research.

[53]  J. Downey,et al.  Multiple, brief coronary occlusions during early reperfusion protect rabbit hearts by targeting cell signaling pathways. , 2004, Journal of the American College of Cardiology.

[54]  S. Levitsky,et al.  Differential contribution of necrosis and apoptosis in myocardial ischemia-reperfusion injury. , 2004, American journal of physiology. Heart and circulatory physiology.

[55]  G. Valen,et al.  Ischemic postconditioning: brief ischemia during reperfusion converts persistent ventricular fibrillation into regular rhythm. , 2004, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[56]  M. Mocanu,et al.  Cross-talk between the survival kinases during early reperfusion: its contribution to ischemic preconditioning. , 2004, Cardiovascular research.

[57]  P. Whittaker,et al.  Reduction of infarct size in vivo with ischemic preconditioning: Mathematical evidence for protection via non-ischemic tissue , 2004, Basic Research in Cardiology.

[58]  R. Guyton,et al.  Myocardial protection with postconditioning is not enhanced by ischemic preconditioning. , 2004, The Annals of thoracic surgery.

[59]  M. Duchen,et al.  Preconditioning protects by inhibiting the mitochondrial permeability transition. , 2004, American journal of physiology. Heart and circulatory physiology.

[60]  M. Mocanu,et al.  Postconditioning: A Form of “Modified Reperfusion” Protects the Myocardium by Activating the Phosphatidylinositol 3-Kinase–Akt Pathway , 2004, Circulation research.

[61]  L. Opie,et al.  Pharmacological Preconditioning With Tumor Necrosis Factor-α Activates Signal Transducer and Activator of Transcription-3 at Reperfusion Without Involving Classic Prosurvival Kinases (Akt and Extracellular Signal–Regulated Kinase) , 2005, Circulation.

[62]  M. Mocanu,et al.  Glucagon Like Peptide-1 is Protective Against Myocardial Ischemia/Reperfusion Injury when Given Either as a Preconditioning Mimetic or at Reperfusion in an Isolated Rat Heart Model , 2005, Cardiovascular Drugs and Therapy.

[63]  L. Argaud,et al.  Postconditioning Inhibits Mitochondrial Permeability Transition , 2005, Circulation.

[64]  Tetsuya Watanabe,et al.  Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death , 2005, Nature.

[65]  M. Ovize,et al.  Low-pressure reperfusion alters mitochondrial permeability transition. , 2005, American journal of physiology. Heart and circulatory physiology.

[66]  G. Finet,et al.  Postconditioning the Human Heart , 2005, Circulation.

[67]  L. Agulló,et al.  Antagonism of selectin function attenuates microvascular platelet deposition and platelet-mediated myocardial injury after transient ischemia. , 2005, Journal of the American College of Cardiology.

[68]  G. Heusch,et al.  Connexin 43 in cardiomyocyte mitochondria and its increase by ischemic preconditioning. , 2005, Cardiovascular research.

[69]  E. Iliodromitis,et al.  Repeated exercise stress testing identifies early and late preconditioning. , 2005, International journal of cardiology.

[70]  Lino Gonçalves,et al.  Diabetes and cardiovascular disease: the road to cardioprotection , 2005, Heart.

[71]  Xiaokui Li,et al.  Impairment of Diazoxide-Induced Formation of Reactive Oxygen Species and Loss of Cardioprotection in Connexin 43 Deficient Mice , 2005, Circulation research.

[72]  Jeffrey Robbins,et al.  Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death , 2005, Nature.

[73]  D. Yellon,et al.  The reperfusion injury salvage kinase pathway: a common target for both ischemic preconditioning and postconditioning. , 2005, Trends in cardiovascular medicine.

[74]  M. Mocanu,et al.  Ischemic preconditioning protects by activating prosurvival kinases at reperfusion. , 2005, American journal of physiology. Heart and circulatory physiology.

[75]  M. Mocanu,et al.  Glucagon-like peptide 1 can directly protect the heart against ischemia/reperfusion injury. , 2005, Diabetes.

[76]  J. Deanfield,et al.  Remote ischemic preconditioning provides early and late protection against endothelial ischemia-reperfusion injury in humans: role of the autonomic nervous system. , 2005, Journal of the American College of Cardiology.

[77]  M. Mocanu,et al.  Preconditioning the diabetic heart: the importance of Akt phosphorylation. , 2005, Diabetes.

[78]  I. Konstantinov,et al.  Randomized controlled trial of the effects of remote ischemic preconditioning on children undergoing cardiac surgery: first clinical application in humans. , 2006, Journal of the American College of Cardiology.

[79]  I. West,et al.  The Mechanism by Which the Mitochondrial ATP-sensitive K+ Channel Opening and H2O2 Inhibit the Mitochondrial Permeability Transition* , 2006, Journal of Biological Chemistry.

[80]  M. Duchen,et al.  Signalling via the reperfusion injury signalling kinase (RISK) pathway links closure of the mitochondrial permeability transition pore to cardioprotection. , 2006, The international journal of biochemistry & cell biology.

[81]  G. Heusch,et al.  Translocation of Connexin 43 to the Inner Mitochondrial Membrane of Cardiomyocytes Through the Heat Shock Protein 90–Dependent TOM Pathway and Its Importance for Cardioprotection , 2006, Circulation research.

[82]  M. Duchen,et al.  Calcium microdomains and oxidative stress. , 2006, Cell calcium.

[83]  G. Heusch,et al.  Connexin 43 in ischemic pre- and postconditioning , 2007, Heart Failure Reviews.

[84]  M. Hayward,et al.  Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomised controlled trial , 2007, The Lancet.

[85]  Z. Ali,et al.  Remote Ischemic Preconditioning Reduces Myocardial and Renal Injury After Elective Abdominal Aortic Aneurysm Repair: A Randomized Controlled Trial , 2007, Circulation.

[86]  J. Holst.  The physiology of glucagon-like peptide 1. , 2007, Physiological reviews.

[87]  P. Ferdinandy,et al.  Interaction of Cardiovascular Risk Factors with Myocardial Ischemia/Reperfusion Injury, Preconditioning, and Postconditioning , 2007, Pharmacological Reviews.

[88]  J. Downey,et al.  The pH Hypothesis of Postconditioning: Staccato Reperfusion Reintroduces Oxygen and Perpetuates Myocardial Acidosis , 2007, Circulation.

[89]  Gemma Vilahur,et al.  Early Metoprolol Administration Before Coronary Reperfusion Results in Increased Myocardial Salvage: Analysis of Ischemic Myocardium at Risk Using Cardiac Magnetic Resonance , 2007, Circulation.

[90]  David Garcia-Dorado,et al.  Loss of ischemic preconditioning's cardioprotection in aged mouse hearts is associated with reduced gap junctional and mitochondrial levels of connexin 43. , 2007, American journal of physiology. Heart and circulatory physiology.

[91]  M. Ruiz-Meana,et al.  Opening of mitochondrial permeability transition pore induces hypercontracture in Ca2+ overloaded cardiac myocytes , 2007 .

[92]  I. Konstantinov,et al.  Intermittent peripheral tissue ischemia during coronary ischemia reduces myocardial infarction through a KATP-dependent mechanism: first demonstration of remote ischemic perconditioning. , 2007, American journal of physiology. Heart and circulatory physiology.

[93]  D. Yellon,et al.  Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection , 2007, Heart Failure Reviews.

[94]  T. Engstrøm,et al.  Protective effects of GLP-1 analogues exendin-4 and GLP-1(9–36) amide against ischemia–reperfusion injury in rat heart , 2008, Regulatory Peptides.

[95]  G. Finet,et al.  Long-Term Benefit of Postconditioning , 2008, Circulation.

[96]  L. Opie,et al.  Dual activation of STAT-3 and Akt is required during the trigger phase of ischaemic preconditioning. , 2008, Cardiovascular research.

[97]  E. Iliodromitis,et al.  Treadmill exercise test with dual isotope scintigraphy documents the second window of preconditioning in humans. , 2008, Atherosclerosis.

[98]  D. Drucker,et al.  Cardioprotective and Vasodilatory Actions of Glucagon-Like Peptide 1 Receptor Are Mediated Through Both Glucagon-Like Peptide 1 Receptor–Dependent and –Independent Pathways , 2008, Circulation.

[99]  D. Yellon,et al.  Time to take myocardial reperfusion injury seriously. , 2008, The New England journal of medicine.

[100]  D. Yellon,et al.  GLP-1 therapy: beyond glucose control. , 2008, Circulation. Heart failure.

[101]  J. Stamler,et al.  Redox-based regulation of signal transduction: principles, pitfalls, and promises. , 2008, Free radical biology & medicine.

[102]  D. Yellon,et al.  Remote ischaemic preconditioning: underlying mechanisms and clinical application. , 2008, Cardiovascular research.

[103]  J. Downey,et al.  Redox signaling triggers protection during the reperfusion rather than the ischemic phase of preconditioning , 2008, Basic Research in Cardiology.

[104]  Pierre Croisille,et al.  Effect of cyclosporine on reperfusion injury in acute myocardial infarction. , 2008, The New England journal of medicine.

[105]  J. Vázquez,et al.  Connexin43 in cardiomyocyte mitochondria contributes to mitochondrial potassium uptake. , 2009, Cardiovascular research.

[106]  M. Ruiz-Meana,et al.  Lethal reperfusion injury in acute myocardial infarction: facts and unresolved issues. , 2009, Cardiovascular research.

[107]  M. Marber,et al.  Lizard spit and reperfusion injury. , 2009, Journal of the American College of Cardiology.

[108]  D. Yellon,et al.  Remote ischaemic preconditioning reduces myocardial injury in patients undergoing cardiac surgery with cold-blood cardioplegia: a randomised controlled trial , 2009, Heart.

[109]  S. Lecour,et al.  Multiple protective pathways against reperfusion injury: a SAFE path without Aktion? , 2009, Journal of molecular and cellular cardiology.

[110]  G. Heusch,et al.  Presence of connexin 43 in subsarcolemmal, but not in interfibrillar cardiomyocyte mitochondria , 2009, Basic Research in Cardiology.

[111]  D. Yellon,et al.  The mitochondrial permeability transition pore as a target for preconditioning and postconditioning , 2009, Basic Research in Cardiology.

[112]  G. Heusch,et al.  Inhibition of mitochondrial permeability transition pore opening: the holy grail of cardioprotection , 2010, Basic Research in Cardiology.

[113]  K. Shimamoto,et al.  ORIGINAL ARTICLE Endoplasmic Reticulum Stress in Diabetic Hearts Abolishes Erythropoietin-Induced Myocardial Protection by Impairment of Phospho–Glycogen Synthase Kinase-3�–Mediated Suppression of Mitochondrial Permeability Transition , 2022 .

[114]  L. Sharples,et al.  Cardiac Remote Ischemic Preconditioning in Coronary Stenting (CRISP Stent) Study: A Prospective, Randomized Control Trial , 2009, Circulation.

[115]  P. Doevendans,et al.  Exenatide reduces infarct size and improves cardiac function in a porcine model of ischemia and reperfusion injury. , 2009, Journal of the American College of Cardiology.

[116]  P. Hayes,et al.  Remote Ischemic Preconditioning for Renal and Cardiac Protection during Endovascular Aneurysm Repair: A Randomized Controlled Trial , 2009, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.

[117]  S. Lecour.  Activation of the protective Survivor Activating Factor Enhancement (SAFE) pathway against reperfusion injury: Does it go beyond the RISK pathway? , 2009, Journal of molecular and cellular cardiology.

[118]  L. Opie,et al.  Ischaemic postconditioning protects against reperfusion injury via the SAFE pathway. , 2009, Cardiovascular research.

[119]  G. Heusch,et al.  Loss of cardioprotection with ageing. , 2009, Cardiovascular research.

[120]  Claes Held,et al.  Ticagrelor versus clopidogrel in patients with acute coronary syndromes. , 2009, The New England journal of medicine.

[121]  G. Heusch,et al.  Ischemic Postconditioning in Pigs: No Causal Role for Risk Activation , 2008, Circulation research.

[122]  A. Abellán,et al.  Role of sarcoplasmic reticulum in mitochondrial permeability transition and cardiomyocyte death during reperfusion. , 2009, American journal of physiology. Heart and circulatory physiology.

[123]  Elena Kuzmin,et al.  Transient limb ischaemia remotely preconditions through a humoral mechanism acting directly on the myocardium: evidence suggesting cross-species protection. , 2009, Clinical science.

[124]  A. Redington,et al.  Pretreatment with the nitric oxide donor SNAP or nerve transection blocks humoral preconditioning by remote limb ischemia or intra-arterial adenosine. , 2010, American journal of physiology. Heart and circulatory physiology.

[125]  M. Frenneaux,et al.  Response to Letter Regarding Article, “Remote Ischemic Preconditioning in Human Coronary Artery Bypass Surgery: From Promise to Disappointment?” , 2011 .

[126]  M. Mirabet,et al.  Antagonism of P2Y12 or GPIIb/IIIa receptors reduces platelet-mediated myocardial injury after ischaemia and reperfusion in isolated rat hearts , 2010, Thrombosis and Haemostasis.

[127]  G. Heusch,et al.  Reduction of infarct size by gentle reperfusion without activation of reperfusion injury salvage kinases in pigs. , 2010, Cardiovascular research.

[128]  L. Opie,et al.  TNFα protects cardiac mitochondria independently of its cell surface receptors , 2010, Basic Research in Cardiology.

[129]  E. Larsson,et al.  Cyclosporine Does Not Reduce Myocardial Infarct Size in a Porcine Ischemia-Reperfusion Model , 2010, Journal of cardiovascular pharmacology and therapeutics.

[130]  G. Heusch,et al.  Inhibition of permeability transition pore opening by mitochondrial STAT3 and its role in myocardial ischemia/reperfusion , 2010, Basic Research in Cardiology.

[131]  T. Miura,et al.  Mitochondrial kinase signalling pathways in myocardial protection from ischaemia/reperfusion-induced necrosis. , 2010, Cardiovascular research.

[132]  N. Ali,et al.  Induced remote ischemic pre-conditioning on ischemia-reperfusion injury in patients undergoing coronary artery bypass. , 2010, Journal of the College of Physicians and Surgeons--Pakistan : JCPSP.

[133]  D. Yellon,et al.  Preconditioning the diabetic human myocardium , 2009, Journal of cellular and molecular medicine.

[134]  Charalampos Kossyvakis,et al.  Cardioprotective role of remote ischemic periconditioning in primary percutaneous coronary intervention: enhancement by opioid action. , 2010, JACC. Cardiovascular interventions.

[135]  G. Heusch,et al.  Cyclosporine A at Reperfusion Reduces Infarct Size in Pigs , 2010, Cardiovascular Drugs and Therapy.

[136]  C. Terkelsen,et al.  Remote Ischemic Conditioning in Patients With Myocardial Infarction Treated With Primary Angioplasty: Impact on Left Ventricular Function Assessed by Comprehensive Echocardiography and Gated Single-Photon Emission CT , 2010, Circulation. Cardiovascular imaging.

[137]  J. Jensen,et al.  Glucagon-like peptide 1--a cardiologic dimension. , 2010, Trends in cardiovascular medicine.

[138]  G. Heusch,et al.  Remote ischemic preconditioning reduces myocardial injury after coronary artery bypass surgery with crystalloid cardioplegic arrest , 2010, Basic Research in Cardiology.

[139]  D. Yellon,et al.  The neural and humoral pathways in remote limb ischemic preconditioning , 2010, Basic Research in Cardiology.

[140]  C. Terkelsen,et al.  Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial , 2010, The Lancet.

[141]  D. Yellon,et al.  Mitochondrial cyclophilin-D as a critical mediator of ischaemic preconditioning , 2010, Cardiovascular research.

[142]  M. Ruiz-Meana,et al.  The SR-mitochondria interaction: a new player in cardiac pathophysiology. , 2010, Cardiovascular research.

[143]  K. Shimamoto,et al.  Short Communication: Angiotensin II Type 1 Receptor–Mediated Upregulation of Calcineurin Activity Underlies Impairment of Cardioprotective Signaling in Diabetic Hearts , 2010, Circulation research.

[144]  P. Croisille,et al.  Effect of cyclosporine on left ventricular remodeling after reperfused myocardial infarction. , 2010, Journal of the American College of Cardiology.

[145]  I. Konstantinov,et al.  Remote ischemic preconditioning decreases adhesion and selectively modifies functional responses of human neutrophils. , 2010, The Journal of surgical research.

[146]  A. Shah,et al.  Remote intermittent ischemia before coronary artery bypass graft surgery: a strategy to reduce injury and inflammation? , 2011, Basic Research in Cardiology.

[147]  L. Opie,et al.  Is red wine a SAFE sip away from cardioprotection? Mechanisms involved in resveratrol‐ and melatonin‐induced cardioprotection , 2011, Journal of pineal research.

[148]  G. Heusch,et al.  Mitochondrial STAT3 Activation and Cardioprotection by Ischemic Postconditioning in Pigs With Regional Myocardial Ischemia/Reperfusion , 2011, Circulation research.

[149]  J. Inserte,et al.  The role of mitochondrial permeability transition in reperfusion-induced cardiomyocyte death depends on the duration of ischemia , 2011, Basic Research in Cardiology.

[150]  Michael V. Cohen,et al.  Ischemic postconditioning: from receptor to end-effector. , 2011, Antioxidants & redox signaling.

[151]  D. Yellon,et al.  Reperfusion injury salvage kinase and survivor activating factor enhancement prosurvival signaling pathways in ischemic postconditioning: two sides of the same coin. , 2011, Antioxidants & redox signaling.

[152]  D. Yellon,et al.  Investigating the Signal Transduction Pathways Underlying Remote Ischemic Conditioning in the Porcine Heart , 2012, Cardiovascular Drugs and Therapy.

[153]  H. Swanton,et al.  Effect of erythropoietin as an adjunct to primary percutaneous coronary intervention: a randomised controlled clinical trial , 2011, Heart.

[154]  S. Combes,et al.  Delayed Postconditioning in the Mouse Heart In Vivo , 2011, Circulation.

[155]  R. Gladstone,et al.  Remote cardioprotection by direct peripheral nerve stimulation and topical capsaicin is mediated by circulating humoral factors , 2012, Basic Research in Cardiology.

[156]  堀田 寛之.  Angiotensin II type 1 receptor-mediated upregulation of calcineurin activity underlies impairment of cardioprotective signaling in diabetic hearts , 2011 .

[157]  M. Hayward,et al.  Failure to recapture cardioprotection with high-dose atorvastatin in coronary artery bypass surgery: a randomised controlled trial , 2011, Basic Research in Cardiology.

[158]  A. Rodríguez-Sinovas,et al.  Contribution of delayed intracellular pH recovery to ischemic postconditioning protection. , 2011, Antioxidants & redox signaling.

[159]  D. Newby,et al.  Remote ischemic preconditioning prevents systemic platelet activation associated with ischemia–reperfusion injury in humans , 2011, Journal of thrombosis and haemostasis : JTH.

[160]  F. Crea,et al.  Upper arm intermittent ischaemia reduces exercise-related increase of platelet reactivity in patients with obstructive coronary artery disease , 2011, Heart.

[161]  A. Redington,et al.  Repeated Remote Ischemic Postconditioning Protects Against Adverse Left Ventricular Remodeling and Improves Survival in a Rat Model of Myocardial Infarction , 2011, Circulation research.

[162]  R. Gladstone,et al.  Remote preconditioning provides potent cardioprotection via PI3K/Akt activation and is associated with nuclear accumulation of β-catenin. , 2011, Clinical science.

[163]  P. Croisille,et al.  Post-conditioning reduces infarct size and edema in patients with ST-segment elevation myocardial infarction. , 2012, Journal of the American College of Cardiology.

[164]  D. Yellon,et al.  Taking lizard saliva to heart. , 2012, European heart journal.

[165]  T. Pozzan,et al.  Mitochondrial Ca2+ uptake contributes to buffering cytoplasmic Ca2+ peaks in cardiomyocytes , 2012, Proceedings of the National Academy of Sciences.

[166]  S. Lecour,et al.  High density lipoprotein/sphingosine-1-phosphate-induced cardioprotection , 2012, JAK-STAT.

[167]  C. Terkelsen,et al.  Exenatide Reduces Final Infarct Size in Patients With ST-Segment–Elevation Myocardial Infarction and Short-Duration of Ischemia , 2012, Circulation. Cardiovascular interventions.

[168]  T. Miura,et al.  Cytoprotective regulation of the mitochondrial permeability transition pore is impaired in type 2 diabetic Goto-Kakizaki rat hearts. , 2012, Journal of molecular and cellular cardiology.

[169]  T. Miura,et al.  Effects of diabetes on myocardial infarct size and cardioprotection by preconditioning and postconditioning , 2012, Cardiovascular Diabetology.

[170]  L. Opie,et al.  Interplay Between SAFE and RISK Pathways in Sphingosine-1-Phosphate–Induced Cardioprotection , 2012, Cardiovascular Drugs and Therapy.

[171]  T. Miura,et al.  The mPTP and its regulatory proteins: final common targets of signalling pathways for protection against necrosis. , 2012, Cardiovascular research.

[172]  G. Heusch,et al.  STAT5 Activation and Cardioprotection by Remote Ischemic Preconditioning in Humans , 2012, Circulation research.

[173]  M. Mercola,et al.  Mitochondrial connexin 43 impacts on respiratory complex I activity and mitochondrial oxygen consumption , 2012, Journal of cellular and molecular medicine.

[174]  J. Downey,et al.  Two Classes of Anti-Platelet Drugs Reduce Anatomical Infarct Size in Monkey Hearts , 2013, Cardiovascular Drugs and Therapy.

[175]  J. Holst,et al.  Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction. , 2012, European heart journal.

[176]  A. Rodríguez-Sinovas,et al.  Calcium-mediated cell death during myocardial reperfusion. , 2012, Cardiovascular research.

[177]  M. Mocanu,et al.  The Diabetic Heart: Too Sweet for Its Own Good? , 2012, Cardiology research and practice.

[178]  Y. Jeon,et al.  Effects of remote ischemic preconditioning with postconditioning in patients undergoing off-pump coronary artery bypass surgery--randomized controlled trial. , 2012, Circulation journal : official journal of the Japanese Circulation Society.

[179]  J. Inserte,et al.  Contribution of calpains to myocardial ischaemia/reperfusion injury. , 2012, Cardiovascular research.

[180]  M. Duchen,et al.  Slow calcium waves and redox changes precede mitochondrial permeability transition pore opening in the intact heart during hypoxia and reoxygenation. , 2012, Cardiovascular research.

[181]  John Miller,et al.  A pilot study investigating the effects of remote ischemic preconditioning in high-risk cardiac surgery using a randomised controlled double-blind protocol , 2012, Basic Research in Cardiology.

[182]  H. Bøtker,et al.  Release of a humoral circulating cardioprotective factor by remote ischemic preconditioning is dependent on preserved neural pathways in diabetic patients , 2012, Basic Research in Cardiology.

[183]  E. Lucchinetti,et al.  Remote Ischemic Preconditioning Applied during Isoflurane Inhalation Provides No Benefit to the Myocardium of Patients Undergoing On-pump Coronary Artery Bypass Graft Surgery: Lack of Synergy or Evidence of Antagonism in Cardioprotection? , 2012, Anesthesiology.

[184]  G. Heusch,et al.  Protection by remote ischemic preconditioning during coronary artery bypass graft surgery with isoflurane but not propofol – a clinical trial , 2012, Acta anaesthesiologica Scandinavica.

[185]  D. Yellon,et al.  Cyclosporin A and cardioprotection: from investigative tool to therapeutic agent , 2012, British journal of pharmacology.

[186]  Woo-Shik Kim,et al.  Cardioprotective Effects of Exenatide in Patients With ST-Segment–Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: Results of Exenatide Myocardial Protection in Revascularization Study , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[187]  M. Mocanu,et al.  Dipeptidyl peptidase-4 inhibitors and GLP-1 reduce myocardial infarct size in a glucose-dependent manner , 2013, Cardiovascular Diabetology.

[188]  Adam J. Brown,et al.  Remote Ischemic Preconditioning Improves Outcome at 6 Years After Elective Percutaneous Coronary Intervention: The CRISP Stent Trial Long-term Follow-up , 2013, Circulation. Cardiovascular interventions.

[189]  M. Neuhäuser,et al.  Cardioprotective and prognostic effects of remote ischaemic preconditioning in patients undergoing coronary artery bypass surgery: a single-centre randomised, double-blind, controlled trial , 2013, The Lancet.

[190]  J. Vicencio,et al.  Remote ischaemic preconditioning involves signalling through the SDF-1α/CXCR4 signalling axis , 2013, Basic Research in Cardiology.

[191]  J. Downey,et al.  Triple Therapy Greatly Increases Myocardial Salvage During Ischemia/Reperfusion in the in situ Rat Heart , 2013, Cardiovascular Drugs and Therapy.

[192]  G. Dorn,et al.  SR and mitochondria: calcium cross-talk between kissing cousins. , 2013, Journal of molecular and cellular cardiology.

[193]  J. Inserte,et al.  Role of the parasympathetic nervous system in cardioprotection by remote hindlimb ischaemic preconditioning , 2013, Experimental physiology.

[194]  G. Heusch.  Cardioprotection: chances and challenges of its translation to the clinic , 2013, The Lancet.

[195]  Sang-Wook Kim,et al.  Ischemic Postconditioning During Primary Percutaneous Coronary Intervention: The Effects of Postconditioning on Myocardial Reperfusion in Patients With ST-Segment Elevation Myocardial Infarction (POST) Randomized Trial , 2013, Circulation.

[196]  Michael V. Cohen,et al.  Platelet P2Y12 Blockers Confer Direct Postconditioning-Like Protection in Reperfused Rabbit Hearts , 2013, Journal of cardiovascular pharmacology and therapeutics.

[197]  D. Yellon,et al.  Myocardial ischemia-reperfusion injury: a neglected therapeutic target. , 2013, The Journal of clinical investigation.

[198]  P. Whittaker,et al.  Genesis of remote conditioning: action at a distance – ‘hypotheses non fingo’? , 2013, Journal of cardiovascular medicine.

[199]  Suraj Khanal,et al.  Effect of early metoprolol on infarct size in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: The effect of metoprolol in cardioprotection during an acute myocardial infarction (METOCARD-CNIC) trial , 2013, Indian Heart Journal.

[200]  A. Íñiguez,et al.  Effect of Early Metoprolol on Infarct Size in ST-Segment–Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention: The Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) Trial , 2013, Circulation.

[201]  M. Gilard,et al.  The RIPOST-MI study, assessing remote ischemic perconditioning alone or in combination with local ischemic postconditioning in ST-segment elevation myocardial infarction , 2014, Basic Research in Cardiology.

[202]  J. Inserte,et al.  Activation of cGMP/Protein Kinase G Pathway in Postconditioned Myocardium Depends on Reduced Oxidative Stress and Preserved Endothelial Nitric Oxide Synthase Coupling , 2013, Journal of the American Heart Association.

[203]  E. Bramucci,et al.  Remote ischemic post-conditioning of the lower limb during primary percutaneous coronary intervention safely reduces enzymatic infarct size in anterior myocardial infarction: a randomized controlled trial. , 2013, JACC. Cardiovascular interventions.

[204]  D. Hausenloy.  Cardioprotection techniques: preconditioning, postconditioning and remote conditioning (basic science). , 2013, Current pharmaceutical design.

[205]  Jeroen J. Bax,et al.  ST-segment Elevation Myocardial Infarction 3 Future treatment strategies in ST-segment elevation myocardial infarction , 2013 .

[206]  L. Opie,et al.  HDL protects against ischemia reperfusion injury by preserving mitochondrial integrity. , 2013, Atherosclerosis.

[207]  D. Shi,et al.  Remote ischemic preconditioning reduces myocardial injury in patients undergoing coronary stent implantation. , 2013, The Canadian journal of cardiology.

[208]  D. Holmes,et al.  Remote ischemic preconditioning immediately before percutaneous coronary intervention does not impact myocardial necrosis, inflammatory response, and circulating endothelial progenitor cell counts: A single center randomized sham controlled trial , 2013, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[209]  Edward T Chouchani,et al.  Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS , 2014, Nature.

[210]  H. Bøtker,et al.  Remote ischemic conditioning: from experimental observation to clinical application: report from the 8th Biennial Hatter Cardiovascular Institute Workshop , 2014, Basic Research in Cardiology.

[211]  R. Gladstone,et al.  MicroRNA-144 is a circulating effector of remote ischemic preconditioning , 2014, Basic Research in Cardiology.

[212]  V. Fuster,et al.  Long-term benefit of early pre-reperfusion metoprolol administration in patients with acute myocardial infarction: results from the METOCARD-CNIC trial (Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction). , 2014, Journal of the American College of Cardiology.

[213]  R. Gladstone,et al.  Transcutaneous electrical nerve stimulation as a novel method of remote preconditioning: in vitro validation in an animal model and first human observations , 2014, Basic Research in Cardiology.

[214]  Wade M. Lee,et al.  Cardioprotective role of ischemic postconditioning in acute myocardial infarction: a systematic review and meta-analysis. , 2014, American heart journal.

[215]  G. Heusch,et al.  Interference of propofol with signal transducer and activator of transcription 5 activation and cardioprotection by remote ischemic preconditioning during coronary artery bypass grafting. , 2014, The Journal of thoracic and cardiovascular surgery.

[216]  Peter Libby,et al.  Cardiovascular remodelling in coronary artery disease and heart failure , 2014, The Lancet.

[217]  Y. Horio,et al.  Translocation of Glycogen Synthase Kinase-3β (GSK-3β), a Trigger of Permeability Transition, Is Kinase Activity-dependent and Mediated by Interaction with Voltage-dependent Anion Channel 2 (VDAC2)* , 2014, The Journal of Biological Chemistry.

[218]  B. McCrindle,et al.  Remote Ischemic Preconditioning in Children Undergoing Cardiac Surgery With Cardiopulmonary Bypass: A Single‐Center Double‐Blinded Randomized Trial , 2014, Journal of the American Heart Association.

[219]  P. Ferdinandy,et al.  Interaction of Risk Factors, Comorbidities, and Comedications with Ischemia/Reperfusion Injury and Cardioprotection by Preconditioning, Postconditioning, and Remote Conditioning , 2014, Pharmacological Reviews.

[220]  D. Katritsis,et al.  Effect of one-cycle remote ischemic preconditioning to reduce myocardial injury during percutaneous coronary intervention. , 2014, The American journal of cardiology.

[221]  K. Preissner,et al.  RNase1 prevents the damaging interplay between extracellular RNA and tumour necrosis factor-α in cardiac ischaemia/reperfusion injury , 2014, Thrombosis and Haemostasis.

[222]  Deepak L. Bhatt,et al.  Surrogate and clinical outcomes following ischemic postconditioning during primary percutaneous coronary intervention of ST‐Segment elevation myocardial infarction: A meta‐analysis of 15 randomized trials , 2014, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[223]  J. Vázquez,et al.  Ischemic preconditioning protects cardiomyocyte mitochondria through mechanisms independent of cytosol. , 2014, Journal of molecular and cellular cardiology.

[224]  H. Bøtker,et al.  Improved long-term clinical outcomes in patients with ST-elevation myocardial infarction undergoing remote ischaemic conditioning as an adjunct to primary percutaneous coronary intervention. , 2014, European heart journal.

[225]  J. Vázquez,et al.  Defective sarcoplasmic reticulum–mitochondria calcium exchange in aged mouse myocardium , 2014, Cell Death and Disease.

[226]  M. Totzeck,et al.  Circulating Nitrite Contributes to Cardioprotection by Remote Ischemic Preconditioning , 2014, Circulation research.

[227]  F. Gao,et al.  Effect of Remote Ischemic Preconditioning in the Elderly Patients With Coronary Artery Disease With Diabetes Mellitus Undergoing Elective Drug-Eluting Stent Implantation , 2014, Angiology.

[228]  G. Rodrigo,et al.  Remote ischemic preconditioning of cardiomyocytes inhibits the mitochondrial permeability transition pore independently of reduced calcium‐loading or sarcKATP channel activation , 2014, Physiological reports.

[229]  R. Guieu,et al.  Ticagrelor increases adenosine plasma concentration in patients with an acute coronary syndrome. , 2014, Journal of the American College of Cardiology.

[230]  K. Preissner,et al.  Abstract 20396: Induction of Ischemia-Reperfusion Injury by Extracellular RNA: A case for Tumor Necrosis Factor (TNF-α) - Shedding , 2014 .

[231]  M. Hayward,et al.  Effect of remote ischaemic preconditioning on clinical outcomes in patients undergoing cardiac bypass surgery: a randomised controlled clinical trial , 2014, Heart.

[232]  H. Bøtker,et al.  The Third DANish Study of Optimal Acute Treatment of Patients with ST-segment Elevation Myocardial Infarction: Ischemic postconditioning or deferred stent implantation versus conventional primary angioplasty and complete revascularization versus treatment of culprit lesion only: Rationale and design , 2015, American heart journal.

[233]  J. Vázquez,et al.  Altered FoF1 ATP synthase and susceptibility to mitochondrial permeability transition pore during ischaemia and reperfusion in aging cardiomyocytes , 2015, Thrombosis and Haemostasis.

[234]  Y. Song,et al.  Effect of ischemic postconditioning on myocardial salvage in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: cardiac magnetic resonance substudy of the POST randomized trial , 2015, The International Journal of Cardiovascular Imaging.

[235]  G. Heusch.  Molecular basis of cardioprotection: signal transduction in ischemic pre-, post-, and remote conditioning. , 2015, Circulation research.

[236]  D. Hasenclever,et al.  A Multicenter Trial of Remote Ischemic Preconditioning for Heart Surgery. , 2015, The New England journal of medicine.

[237]  J. Inserte,et al.  The cGMP/PKG pathway as a common mediator of cardioprotection: translatability and mechanism , 2015, British journal of pharmacology.

[238]  H. Bøtker,et al.  Effect of remote ischaemic conditioning on clinical outcomes in patients presenting with an ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. , 2015, European heart journal.

[239]  H. Bøtker,et al.  Remote ischemic conditioning. , 2015, Journal of the American College of Cardiology.

[240]  G. Heusch.  CIRCUS: a kiss of death for cardioprotection? , 2015, Cardiovascular research.

[241]  D. Hausenloy,et al.  Role of the MPTP in conditioning the heart – translatability and mechanism , 2015, British journal of pharmacology.

[242]  D. Yellon,et al.  Remote Ischemic Conditioning Reduces Myocardial Infarct Size in STEMI Patients Treated by Thrombolysis. , 2015, Journal of the American College of Cardiology.

[243]  D. Hausenloy,et al.  The mitochondrial permeability transition pore and its role in myocardial ischemia reperfusion injury. , 2015, Journal of molecular and cellular cardiology.

[244]  P. Bernardi,et al.  The mitochondrial permeability transition pore: Molecular nature and role as a target in cardioprotection , 2015, Journal of molecular and cellular cardiology.

[245]  M. Mayr,et al.  Functional Genomics of Cardioprotection by Ischemic Conditioning and the Influence of Comorbid Conditions: Implications in Target Identification. , 2015, Current drug targets.

[246]  Shyr-Chyr Chen,et al.  Hypothermia treatment preserves mitochondrial integrity and viability of cardiomyocytes after ischaemic reperfusion injury. , 2015, Injury.

[247]  V. Fuster,et al.  Efficacy and safety of out-of-hospital intravenous metoprolol administration in anterior ST-segment elevation acute myocardial infarction: insights from the METOCARD-CNIC trial. , 2015, Annals of emergency medicine.

[248]  G. Schuler,et al.  Cardioprotection by combined intrahospital remote ischaemic perconditioning and postconditioning in ST-elevation myocardial infarction: the randomized LIPSIA CONDITIONING trial. , 2015, European heart journal.

[249]  K. Preissner,et al.  RNase1 as a potential mediator of remote ischaemic preconditioning for cardioprotection†. , 2015, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[250]  E. Sena,et al.  Determinants of the Efficacy of Cardiac Ischemic Preconditioning: A Systematic Review and Meta-Analysis of Animal Studies , 2015, PloS one.

[251]  H. Bøtker,et al.  Meeting report from the 2nd International Symposium on New Frontiers in Cardiovascular Research. Protecting the cardiovascular system from ischemia: between bench and bedside , 2015, Basic Research in Cardiology.

[252]  Michael V. Cohen,et al.  Signalling pathways and mechanisms of protection in pre‐ and postconditioning: historical perspective and lessons for the future , 2015, British journal of pharmacology.

[253]  N. Mewton,et al.  Influence of cardiovascular risk factors on infarct size and interaction with mechanical ischaemic postconditioning in ST-elevation myocardial infarction , 2015, Open Heart.

[254]  D. Yellon,et al.  Reducing myocardial infarct size: challenges and future opportunities , 2015, Heart.

[255]  A. Halestrap,et al.  The mitochondrial permeability transition: a current perspective on its identity and role in ischaemia/reperfusion injury. , 2015, Journal of molecular and cellular cardiology.

[256]  Sang-Wook Kim,et al.  Long-term effects of ischemic postconditioning on clinical outcomes: 1-year follow-up of the POST randomized trial. , 2015, American heart journal.

[257]  F. Van de Werf,et al.  Evolving therapies for myocardial ischemia/reperfusion injury. , 2015, Journal of the American College of Cardiology.

[258]  A. Rodríguez-Sinovas,et al.  Combination therapy with remote ischaemic conditioning and insulin or exenatide enhances infarct size limitation in pigs. , 2015, Cardiovascular research.

[259]  P. Macdonald,et al.  Cardio-protective signalling by glyceryl trinitrate and cariporide in a model of donor heart preservation. , 2015, Heart, lung & circulation.

[260]  J. Pepper,et al.  Remote Ischemic Preconditioning and Outcomes of Cardiac Surgery. , 2015, The New England journal of medicine.

[261]  S. K. White,et al.  Remote ischemic conditioning reduces myocardial infarct size and edema in patients with ST-segment elevation myocardial infarction. , 2015, JACC. Cardiovascular interventions.

[262]  N. Mewton,et al.  Cyclosporine before PCI in Patients with Acute Myocardial Infarction. , 2015, The New England journal of medicine.

[263]  J. Downey,et al.  Cardioprotective Properties of the Platelet P2Y12 Receptor Inhibitor, Cangrelor: Protective in Diabetics and Reliant Upon the Presence of Blood , 2015, Cardiovascular Drugs and Therapy.

[264]  D. Hausenloy,et al.  Remote ischaemic conditioning: cardiac protection from afar , 2015, Anaesthesia.

[265]  G. Heusch,et al.  Across-Species Transfer of Protection by Remote Ischemic Preconditioning With Species-Specific Myocardial Signal Transduction by Reperfusion Injury Salvage Kinase and Survival Activating Factor Enhancement Pathways. , 2015, Circulation research.

[266]  B. Gersh,et al.  ERICCA and RIPHeart: two nails in the coffin for cardioprotection by remote ischemic conditioning? Probably not! , 2016, European heart journal.

[267]  G. Heusch,et al.  Time to Give Up on Cardioprotection? A Critical Appraisal of Clinical Studies on Ischemic Pre-, Post-, and Remote Conditioning. , 2016, Circulation research.

[268]  V. Fuster,et al.  Impact of the Timing of Metoprolol Administration During STEMI on Infarct Size and Ventricular Function. , 2016, Journal of the American College of Cardiology.

[269]  D. Yellon,et al.  Co-dependence of the neural and humoral pathways in the mechanism of remote ischemic conditioning , 2016, Basic Research in Cardiology.

[270]  A. Maggioni,et al.  Cyclosporine A in Reperfused Myocardial Infarction: The Multicenter, Controlled, Open-Label CYCLE Trial. , 2016, Journal of the American College of Cardiology.

[271]  H. Bøtker,et al.  Cost-effectiveness of remote ischaemic conditioning as an adjunct to primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction , 2017, European heart journal. Acute cardiovascular care.

[272]  Nirmal Singh,et al.  Investigations on the role of leukotrienes in remote hind limb preconditioning-induced cardioprotection in rats. , 2016, Life sciences.

[273]  P. Doevendans,et al.  No benefit of additional treatment with exenatide in patients with an acute myocardial infarction. , 2016, International journal of cardiology.

[274]  D. Sanchís,et al.  Studies on the role of apoptosis after transient myocardial ischemia: genetic deletion of the executioner caspases-3 and -7 does not limit infarct size and ventricular remodeling , 2016, Basic Research in Cardiology.

[275]  V. Fuster,et al.  Early Intravenous Beta-Blockers in Patients With ST-Segment Elevation Myocardial Infarction Before Primary Percutaneous Coronary Intervention. , 2016, Journal of the American College of Cardiology.

[276]  H. Bøtker,et al.  9th Hatter Biannual Meeting: position document on ischaemia/reperfusion injury, conditioning and the ten commandments of cardioprotection , 2016, Basic Research in Cardiology.

[277]  D. Yellon,et al.  Ischaemic conditioning and reperfusion injury , 2016, Nature Reviews Cardiology.

[278]  O. Ziff,et al.  Remote ischaemic conditioning reduces infarct size in animal in vivo models of ischaemia-reperfusion injury: a systematic review and meta-analysis , 2016, Cardiovascular research.

[279]  H. Bøtker,et al.  Targeting reperfusion injury in patients with ST-segment elevation myocardial infarction: trials and tribulations , 2016, European heart journal.

[280]  B. Gersh,et al.  The pathophysiology of acute myocardial infarction and strategies of protection beyond reperfusion: a continual challenge. , 2016, European heart journal.